The effect of dietary whey protein v. casein on plasma and Liver cholesterol concentrations was investigated in female, weanling rats. Balanced, purified diets containing either whey protein or casein, or the amino acid mixtures simulating these proteins, were used. The high-cholesterol diets (10 g cholesterol/kg feed) had either 150 or 300 g protein or amino acids/kg feed. The diets were fed for 3 weeks. At the low dietary protein level, whey protein v. casein did not affect plasma total cholesterol, but lowered the concentration of liver cholesterol. At the high dietary protein level, whey protein significantly lowered plasma and liver cholesterol and also plasma triacylglycerols. The hypocholesterolaemic effect of whey protein was associated with a decrease in very-low-density-lipoprotein cholesterol. At the high dietary protein concentration, whey protein reduced the faecal excretion of bile acids when compared with casein. The effects of intact whey protein v. casein were not reproduced by the amino acid mixtures simulating these proteins. It is suggested tentatively that the cholesterol-lowering effect of whey protein in rats is caused by inhibition of hepatic cholesterol synthesis.
The type of dietary protein can influence plasma cholesterol concentration (Kritchevsky, 1979 ; Beynen, 1990) . Animal proteins generally exert a hypercholesterolaemic effect when compared with plant proteins (Carroll, 1982) . However, different animal proteins may cause different degrees of hypercholesterolaemia by different mechanisms (Lovati et al. 1990) . Milk-whey protein instead of casein in formulas fed to infants has been shown to lower plasma cholesterol concentrations (Tseng et al. 1990 ). The hypocholesterolaemic effect of dietary whey protein v. casein also occurs in rabbits (Lovati et al. 1990) , whereas in rats inconsistent results have been obtained (Sautier et al. 1983; Choi et al. 1989) .
In the present study using female rats we re-addressed the question of whether milk-whey protein v. casein in the diet influences plasma and liver cholesterol concentrations. In contrast to previous work (Sautier et al. 1983; Choi et al. 1989; Laprk et al. 1989 ) the diets containing either casein or whey protein were isonitrogenous and carefully balanced for residual fat and cholesterol in the protein preparations. Amino acid mixtures simulating either whey protein or casein were fed also to see whether any effects of the intact proteins can be explained by their amino acid composition or rather by protein structure or nonprotein components. The proteins and amino acid mixtures were incorporated into the diets at low (1 50 g/kg diet) and high (300 g/kg diet) levels because protein-type effects on plasma and liver cholesterol concentrations are generally amplified by higher protein intakes (Terpstra et al. 1982; Zhang & Beynen, 1992) . All diets used contained a high concentration of cholesterol (1 0 g/kg diet) to enhance the differential cholesterolaemic responses to the type of protein (Van der Meer & Beynen, 1987) .
M A T E R I A L S A N D M E T H O D S

Diets
The analysed composition and amino acid profile of the casein (Havero bv, Rotterdam, The Netherlands) and milk-whey protein (DMV Campina, Veghel, The Netherlands) preparations are shown in Table 1 . Either the protein preparations or amino acid mixtures simulating either casein or whey protein (Table 1) were used as the only N source in the experimental diets. There were two levels of N source: 150 or 300 g protein or amino acid mixture/kg diet. The diets containing intact proteins were isonitrogenous and balanced for residual fat, cholesterol, Ca, P and Mg in the protein preparations. Dietary cholesterol concentration was 10 g/kg. Table 2 gives the ingredient composition of the experimental diets. The analysed composition of the diets (Table 3) agreed well with the calculated composition. The diets, which were in powdered form, were stored at 4" until feeding. Food and demineralized water were provided on an ad lib. basis.
Animals and experimental procedures
Weanling, female Wistar rats (Hsd/Cpb: WU), aged about 3 weeks, were used. On arrival the rats were given free access to a commercial, pelleted non-purified diet (RMH-B@; Hope Farms, Woerden, The Netherlands) and tap water. They were housed in groups of five rats in Macrolon TI1 cages (UNO BV, Zevenaar, The Netherlands) with a layer of sawdust as bedding.
After 1 week all animals were transferred to the purified, pre-experimental diet and demineralized water. The powdered, pre-experimental diet consisted of the following (g/kg diet) : casein 175.3, soya-bean oil 30, coconut fat 87.2, cholesterol 9.96, cellulose 30, glucose 614.79, CaCO, 12.45, NaH2PO, .2H, O 8.93 , MgCO, 1.37, KCI 1.0, KHCO, 7.0, mineral premix 10, vitamin premix 12. The composition of the mineral and vitamin premix has been described (Grooten et al. 1991) . After another week, on day 0 of the experiment, the rats were divided into eight groups of twelve animals each on the basis of plasma cholesterol concentration and body weight. The eight groups were randomly assigned to the experimental diets ( Table 2 ). The rats had ad lib. access to food and demineralized water. During the experimental period the rats were housed individually in metabolism cages (Tecniplast Gazzada, Buguggiate, Italy). The cages were placed in a room with controlled temperature (20-24"), relative humidity (4045 Yo) and lighting (light 06.00-18.00 hours).
The experiment lasted 21 d. The rats were weighed weekly and feed intake was recorded. On day 21 the rats were anaesthetized with xylazine (6.86 mg/kg, administered intraperitoneally) and ketamine (60 mg/kg, administered intramuscularly) and exsanguinated by aortic puncture. Livers were removed and weighed. The heparinized blood was centrifuged to collect plasma. Livers and plasma were stored at -20" until analysis.
Chemical analyses N in protein preparations and diets was determined by the Kjeldahl method (Joslyn, 1970) . Cholesterol in proteins and diets was determined by gas-liquid chromatography (Nordby & Nagy, 1973) . Crude fat was determined by extraction according to the Soxhlet method (Joslyn, 1970) , and fatty acid composition by the method of Metcalfe et al. (1966) . Ca and Mg in the protein preparations were analysed by atomic absorption spectroscopy after dry ashing and dissolving the ash in 6 mol HCl/I as described previously (Hoek et al. 1988) . t Constant components consisted of the following (g/kg feed): cellulose 30, KCI 1.0, KHCO, 7.0, mineral premix 10, vitamin premix 12. The composition of the mineral and vitamin premix has been described (Grooten et al. 1991) . P in the same samples was analysed enzymically using a commercial kit (MA-KIT Phosphate; Roche, Basel, Switzerland). Cholesterol and triacylglycerols in plasma were measured enzymically using kits (Monotest and Test-Combination) supplied by Boehringer Mannheim GmbH, Mannheim, Germany. Plasma lipoproteins were isolated by density-gradient ultracentrifugation (Terpstra et al. 1981) . The following fractions were obtained (density, d ; g/ml): very-lowdensity lipoprotein (VLDL; d < 1.006), intermediate-density lipoprotein (IDL ; 1.006 < d < 1.019), low-density lipoprotein (LDL; 1.019 < d < 1.063), and high-density lipoprotein 2 (HDL,; 1.063 < d < 1.125) and high-density lipoprotein 3 (HDL,; 1.125 < d < 1.210).
Lipoprotein cholesterol was measured as plasma total cholesterol.
Total faecal 3-cr bile acids were determined with the use of a test combination based on an enzymic, spectrofluorimetric method (Sterognost 3-or Flu; Nyegaard & Co, Oslo, Norway).
Statistical analyses All statistical analyses were carried out with the SPSS/PC+ programme (SPSS Inc., 1986) . The data were subjected to three-way ANOVA with type of N source (casein v. whey protein), form of N source (intact protein v. amino acid mixture), and amount of N source (150 v. 300 g protein or amino acid mixture/kg diet) as main effects. The probability of a type I error < 0.05 was taken as criterion of statistical significance. The main effects were also evaluated in selected, direct comparisons with the use of Student's t test. When testing for effects of type, form and amount of N source in the diet, a P value of 0.017 was used to take into account the increased probability of a type I error because of multiple comparisons.
Final body weights were similar between dietary groups (Table 4) . Whey protein feeding slightly reduced food intake when compared with casein. Rats given amino acid mixtures Tables 1-3. simulating either casein or whey protein consumed similar amounts of feed. Increasing N intake reduced feed intake irrespective of the nature of the N source. Feeding intact whey protein caused significantly lower liver weight than feeding casein. The amino acid mixture corresponding to casein produced lower liver weight than intact casein. Such an effect was not seen with whey protein amino acids. Apart from the groups given intact casein, increasing N intake lowered relative liver weight. At the low dietary protein level, plasma cholesterol concentrations were similar for rats given either intact whey protein or casein (Table 5 ). An increased intake of casein raised the group mean plasma cholesterol concentration, whereas an increased intake of whey protein had the opposite effect. Thus, an increment in protein intake resulted in a significant protein-type effect : whey protein v. casein significantly reduced plasma cholesterol concentration by about 35 YO. The plasma cholesterol lowering as induced by extra whey protein in the diet was most clearly reflected in the VLDL fraction ( Table 6 ) . The influence of the intact proteins on plasma free cholesterol mirrored that on plasma total cholesterol.
At the high dietary N concentration the amino acid mixture simulating casein lowered plasma cholesterol concentrations when compared with intact protein (Table 5 ). The casein amino acids produced lower cholesterol concentrations in VLDL and IDL. Such an effect was not seen at the low dietary N concentration. The amino acid mixture simulating whey protein did not systematically influence plasma cholesterol concentration when compared with intact whey protein. The whey protein amino acids in the diet did not significantly alter plasma cholesterol concentrations when compared with casein amino acids.
Dietary whey protein produced lower group mean plasma triacylglycerol concentrations than casein, but a corresponding N source effect was not found in rats fed on amino acid mixtures simulating either whey protein or casein (Table 5 ). The amino acid mixtures generally lowered triacylglycerols when compared with the intact proteins. Increasing intakes of intact proteins, but not of amino acid mixtures, reduced plasma triacylglycerols.
Whey protein v. casein significantly reduced liver cholesterol concentrations, this effect being greater when dietary protein level was increased (Table 5) . Such an effect of N source 300 g protein or amino acid mixture/kg diet); F, form of N source (intact protein v. amino acid mixture); T x A, T x F, A x F, T x A x F, interactions; t, a, f group comparisons for two groups with one dietary variable (P < 0.017): t, significant N type effect (intact whey protein v. casein or whey protein amino acids v. casein amino acids); a, significant N amount effect (150 u. 300 g protein or amino acid mixture/kg diet); f, significant N form effect (casein amino acids v . intact casein or whey protein amino acids u. intact whey protein). interactions; t, a, f group comparisons for two groups with one dietary variable (P < 0,017): t, significant N type effect (intact whey protein v. casein or whey protein amino acids v. casein amino acids); a, significant N amount effect (1 50 v. 300 g protein or amino acid mixture/kg diet); f, significant N form effect (casein amino acids Y. intact casein or whey protein amino acids v . intact whey protein).
was not seen in rats fed on diets containing the amino acid mixtures. At the two dietary N concentrations the amino acid mixture simulating casein lowered liver cholesterol concentrations when compared with the intact protein. For whey protein at the high dietary N concentration there was an opposite tendency. At the high dietary protein level intact whey protein v. casein significantly reduced the faecal excretion of bile acids (Table 5 ). The two amino acid mixtures did not differently influence bile acid excretion. Apart from the diet containing the high concentration of whey-protein amino acids, the other diets with amino acids produced lower rates of bile acid excretion than the corresponding diets with intact proteins.
DISCUSSION
Conflicting results have been reported as to the effect of dietary whey protein v. casein on plasma and liver cholesterol concentrations in rats. Sautier et al. (1983) , using nonbalanced diets without added cholesterol, found that dietary whey protein produced lower plasma cholesterol concentrations than casein, while liver cholesterol concentration was not significantly reduced. Choi et al. (1989) did not show any effect of whey protein v. casein on plasma and liver cholesterol. In those two studies dietary protein concentration was about 200 g/kg feed. In the present study whey protein reduced liver cholesterol, but not plasma cholesterol, when given at a dietary concentration of 150 g/kg feed. This corroborates the work of Lapre et al. (1989) . However, 300 g whey protein/kg feed instead of an identical amount of casein markedly lowered both plasma and liver cholesterol levels. In rats fed on whey protein at the high level, cholesterol in VLDL was reduced. Since this lipoprotein fraction is a major carrier of plasma triacylglycerols, it is not surprising that group mean total triacylglycerol concentrations in plasma were decreased in rats given the high amount of whey protein.
Thus, whey protein v. casein had cholesterol-lowering activity and, by definition, casein v. whey protein had cholesterol-elevating activity. To see whether the hypocholesterolaemic effect of whey protein can be explained by its amino acid composition, amino acid mixtures simulating either whey protein or casein were also fed. It is appreciated, however, that the effects of amino acid mixtures may not give information about the intact proteins. An intact protein cannot be simply replaced by an amino acid mixture resembling its composition because the order in which peptides or amino acids are released during digestion is characteristic for the intact protein. The differential effect of intact whey protein and casein on plasma and liver cholesterol levels was not seen with the amino acids simulating either whey protein or casein. The amino acid mixtures produced significantly different plasma cholesterol concentrations when compared with the intact corresponding proteins. The results could imply that the cholesterol-lowering activity of whey protein v. casein resides in different protein structure or non-protein components rather than in different amino acid composition per se. In contrast, the hypocholesterolaemic effect of dietary soya-bean protein v. casein in rats has been reproduced by feeding amino acid mixtures formulated to simulate these proteins (Yadav & Liener, 1977; Nagata et al. 1981) .
The hypocholesterolaemic effect of soya-bean protein v. casein may be explained by stimulation of faecal excretion of bile acids and neutral steroids (Beynen, 1990) . In contrast, the mechanism underlying the hypocholesterolaemia produced by the feeding of whey protein instead of casein is not clear. In rabbits, whey protein v. casein slightly lowered plasma total cholesterol concentration, which was associated with increased rates of faecal excretion of neutral steroids and bile acids (Lovati et al. 1990 ). In rats, however, whey protein did not change the excretion of neutral steroids and bile acids in faeces (Sautier et al. 1983) . In the present study whey protein at the high dietary N concentration significantly reduced the faecal excretion of bile acids. Thus, it is unlikely that in rats whey protein v. A N G A N D A. C. B E Y N E N casein inhibits re-absorption of bile acids as has been shown for soya-bean protein v. casein (Beynen, 1990) .
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It is possible that, in rats fed on the high level of whey protein, cholesterol synthesis was inhibited when compared with their counterparts fed on casein. This is indicated by the observation that whey protein induced lower VLDL-cholesterol levels. The lower liver cholesterol concentrations in rats given whey protein could also point to a depressed de HOVO cholesterolgenesis, but the fact that cellular cholesterol usually acts as a feedback inhibitor of cholesterol synthesis speaks against this. Since cholesterol synthesized de novo in the liver is a major precursor of bile acids, the depressed excretion of bile acids in rats given whey protein instead of casein could indicate that whey protein inhibits cholesterol synthesis. Whether dietary whey protein v. casein indeed blocks hepatic cholesterol synthesis or, in other words, whether casein stimulates cholesterol synthesis compared with whey protein can only be proved by direct measurement of cholesterol synthesis.
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